Clinical Trials List
Protocol NumberCA163-200
2009-11-30 - 2011-11-29
Phase II
Terminated2
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chi-Ting Liau Division of Hematology & Oncology
- 曾振輝 Division of Radiology
- Yung-Chang Lin Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
52 participants
